Alpha Tau Medical Ltd.
Last updated September 27, 2026
Organization details
- Legal name
- Alpha Tau Medical Ltd.
- Ownership
- Public
- Status
- Active
- Headquarters country
- Israel
- Ticker symbol
- DRTS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001871321
Board of directors
-
Alan Adler · DirectorSince 2026
-
David Mark Milch · DirectorSince 2026
-
Maya Netser · DirectorSince 2026
-
Michael Avruch · DirectorSince 2026
-
Nadav Kidron · DirectorSince 2026
-
Ruth Alon · DirectorSince 2026
-
S. Morry Blumenfeld · DirectorSince 2026
-
Uzi Sofer · Director · Chief Executive OfficerSince 2026
Chief executives
Uzi Sofer
· Chief Executive Officer
Since March 2026
Board connections
2 of this board's directors also sit on 4 other boards.
- via Nadav Kidron
- via Nadav Kidron
- via Nadav Kidron
- via Ruth Alon
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,562,465
- 12 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 21, 2026 | Levy Raphi Officer (Chief Financial Officer) | Option exercise | +2,871 | $2.98 | $8,556 |
| Aug 21, 2026 | Levy Raphi Officer (Chief Financial Officer) | Open-market sale | −2,871 | $15.00 | $43,073 |
| Aug 11, 2026 | Levy Raphi Officer (Chief Financial Officer) | Option exercise | +17,730 | $2.98 | $52,835 |
| Aug 11, 2026 | Levy Raphi Officer (Chief Financial Officer) | Open-market sale | −17,730 | $14.00 | $248,277 |
| Jul 6, 2026 | Levy Raphi Officer (Chief Financial Officer) | Option exercise | +2,270 | $2.98 | $6,765 |
| Jul 6, 2026 | Levy Raphi Officer (Chief Financial Officer) | Open-market sale | −2,270 | $14.00 | $31,783 |
| Jul 2, 2026 | Levy Raphi Officer (Chief Financial Officer) | Option exercise | +17,873 | $2.98 | $53,262 |
| Jul 2, 2026 | Levy Raphi Officer (Chief Financial Officer) | Open-market sale | −17,873 | $13.00 | $232,397 |
| Jul 1, 2026 | Levy Raphi Officer (Chief Financial Officer) | Option exercise | +2,127 | $2.98 | $6,338 |
| Jul 1, 2026 | Levy Raphi Officer (Chief Financial Officer) | Open-market sale | −2,127 | $13.02 | $27,691 |
| Jun 30, 2026 | Levy Raphi Officer (Chief Financial Officer) | Open-market sale | −20,000 | $12.00 | $240,044 |
| Jun 25, 2026 | Levy Raphi Officer (Chief Financial Officer) | Open-market sale | −4,222 | $11.00 | $46,442 |
| Jun 25, 2026 | Levy Raphi Officer (Chief Financial Officer) | Open-market sale | −15,778 | $11.00 | $173,558 |
| Jun 23, 2026 | Levy Raphi Officer (Chief Financial Officer) | Open-market sale | −15,000 | $9.47 | $142,050 |
| Jun 23, 2026 | Levy Raphi Officer (Chief Financial Officer) | Open-market sale | −2,500 | $10.00 | $25,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.